Gene Expression Signature–Based Prognostic Risk Score in Patients with Primary Central Nervous System Lymphoma-Reference-Cited by-同舟云学术

Gene Expression Signature–Based Prognostic Risk Score in Patients with Primary Central Nervous System Lymphoma

Published:2012-08-20 Issue:20 Volume:18 Page:5672-5681
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Kawaguchi Atsushi,Iwadate Yasuo,Komohara Yoshihiro,Sano Masakazu,Kajiwara Koji,Yajima Naoki,Tsuchiya Naoto,Homma Jumpei,Aoki Hiroshi,Kobayashi Tsutomu,Sakai Yuko,Hondoh Hiroaki,Fujii Yukihiko,Kakuma Tatsuyuki,Yamanaka Ryuya

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deconvolution of cancer methylation patterns determines that altered methylation in cancer is dominated by a non-disease associated proliferation signal;2024-08-23

2. Machine learning-based pathomics signature of histology slides as a novel prognostic indicator in primary central nervous system lymphoma;Journal of Neuro-Oncology;2024-04-01

3. Relevance of different prognostic scores in primary CNS lymphoma in the era of intensified treatment regimens: A retrospective, multicenter analysis of 174 patients;European Journal of Haematology;2024-01-02

4. Cerebrospinal fluid metabolic markers predict prognosis behavior of primary central nervous system lymphoma with high-dose methotrexate-based chemotherapeutic treatment;Neuro-Oncology Advances;2022-12-13

5. Identification of a novel autophagy-related prognostic signature and small molecule drugs for glioblastoma by bioinformatics;BMC Medical Genomics;2022-05-12